Publications by authors named "David Habiel"

Claim this Profile
T
Translational Studies Reveal the Divergent Effects of Simtuzumab Targeting LOXL2 in Idiopathic Pulmonary Fibrosis.
Milena S Espindola, David M Habiel, Ana Lucia Coelho, Tanyalak Parimon, Peter Chen

Fibrosis (Hong Kong)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Features and Stages of Pulmonary Fibrosis Driven by Type 2 Inflammation.
Hamid Mattoo, Dinesh S Bangari, Sheila Cummings, Zachary Humulock, David Habiel

Am J Respir Cell Mol Biol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPF.
Miriam S Hohmann, David M Habiel, Milena S Espindola, Guanling Huang, Isabelle Jones

JCI Insight· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Responses to Targeting Matrix Metalloproteinase 9 in Idiopathic Pulmonary Fibrosis.
Milena S Espindola, David M Habiel, Ana Lucia Coelho, Barry Stripp, William C Parks

Am J Respir Crit Care Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the stem cell factor 248 isoform attenuates the development of pulmonary remodeling disease.
Andrew Rasky, David M Habiel, Susan Morris, Matthew Schaller, Bethany B Moore

Am J Physiol Lung Cell Mol Physiol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHUK/IKK-α loss in lung epithelial cells enhances NSCLC growth associated with HIF up-regulation.
Evangelia Chavdoula, David M Habiel, Eugenia Roupakia, Georgios S Markopoulos, Eleni Vasilaki

Life Sci Alliance· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting MAP3K19 prevents human lung myofibroblast activation both in vitro and in a humanized SCID model of idiopathic pulmonary fibrosis.
Isabelle C Jones, Milena S Espindola, Rohan Narayanan, Ana L Coelho, David M Habiel

Sci Rep· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine.
Dominik Hartl, Rabindra Tirouvanziam, Julie Laval, Catherine M Greene, David Habiel

J Innate Immun· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Syndecan-1 promotes lung fibrosis by regulating epithelial reprogramming through extracellular vesicles.
Tanyalak Parimon, Changfu Yao, David M Habiel, Lingyin Ge, Stephanie A Bora

JCI Insight· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA-PKcs modulates progenitor cell proliferation and fibroblast senescence in idiopathic pulmonary fibrosis.
David M Habiel, Miriam S Hohmann, Milena S Espindola, Ana Lucia Coelho, Isabelle Jones

BMC Pulm Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis.
Yan Geng, Xue Liu, Jiurong Liang, David M Habiel, Vrishika Kulur

JCI Insight· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quercetin Enhances Ligand-induced Apoptosis in Senescent Idiopathic Pulmonary Fibrosis Fibroblasts and Reduces Lung Fibrosis In Vivo.
Miriam S Hohmann, David M Habiel, Ana L Coelho, Waldiceu A Verri, Cory M Hogaboam

Am J Respir Cell Mol Biol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of CD28 T cells in idiopathic pulmonary fibrosis.
David M Habiel, Milena S Espindola, Chris Kitson, Anthony V Azzara, Ana Lucia Coelho

Mucosal Immunol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to D'Alessandro-Gabazza et al.: Risks of Treating Idiopathic Pulmonary Fibrosis with a TAM Receptor Kinase Inhibitor.
Milena S Espindola, David M Habiel, Cory M Hogaboam

Am J Respir Crit Care Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRAIL-Dependent Resolution of Pulmonary Fibrosis.
David M Habiel, Ana Paula Moreira, Ugur B Ismailoglu, Michael P Dunleavy, Karen A Cavassani

Mediators Inflamm· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating monocytes from prostate cancer patients promote invasion and motility of epithelial cells.
Karen A Cavassani, Rebecca J Meza, David M Habiel, Jie-Fu Chen, Alexander Montes

Cancer Med· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR10+ epithelial cells from idiopathic pulmonary fibrosis lungs drive remodeling.
David M Habiel, Milena S Espindola, Isabelle C Jones, Ana Lucia Coelho, Barry Stripp

JCI Insight· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis.
Milena S Espindola, David M Habiel, Rohan Narayanan, Isabelle Jones, Ana L Coelho

Am J Respir Crit Care Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Syndecan-1 Controls Lung Tumorigenesis by Regulating miRNAs Packaged in Exosomes.
Tanyalak Parimon, Rena Brauer, Saundra Y Schlesinger, Ting Xie, Dianhua Jiang, David M Habiel

Am J Pathol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling Idiopathic Pulmonary Fibrosis in Humanized Severe Combined Immunodeficient Mice.
David M Habiel, Milena S Espindola, Ana L Coelho, Cory M Hogaboam

Am J Pathol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divergent roles for Clusterin in Lung Injury and Repair.
David M Habiel, Ana Camelo, Milena Espindola, Timothy Burwell, Richard Hanna

Sci Rep· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis.
Lynne A Murray, David M Habiel, Miriam Hohmann, Ana Camelo, Huilan Shang

JCI Insight· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host-Microbial Interactions: Idiopathic Pulmonary Fibrosis in Technicolor.
David N O'Dwyer, David Habiel, Cory Hogaboam

Am J Respir Crit Care Med· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of Fibroblasts and Myofibroblasts in Pulmonary Fibrosis.
David M Habiel, Cory M Hogaboam

Curr Pathobiol Rep· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute cigarette smoke exposure activates apoptotic and inflammatory programs but a second stimulus is required to induce epithelial to mesenchymal transition in COPD epithelium.
Lynne A Murray, Rebecca Dunmore, Ana Camelo, Carla A Da Silva, Malin J Gustavsson, David M Habiel

Respir Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis